Sales of artificial eyelashes packaged with adhesives rose 31% to $157 million, according to IRI data for multi-outlet retailers for the 52-week period ended March 19. Eyelash adhesives kicked in another $30 million and showed growth of 24%.
Drug and discount stores have managed to lure customers away from specialty and department stores to their doors for color cosmetics, where brows and lashes are leading the charge to attract shoppers, skin care and bubble bath products.
As more Americans wrestle with the cost of their health care, they continue to gravitate toward better lifestyle choices, which means niche products that were at one time only purchased by body builders and serious athletes have become appealing to the mainstream consumer.
One of the biggest trends in food and beverage in the past several years has been in better-for-you offerings — something that’s expected to continue to influence new products as consumers remain focused on what’s in their favorite snacks and beverages.
Although 2016 saw the Food and Drug Administration approve only 22 new drugs compared with 45 approvals in 2015 and the lowest tally since 2010, many in the pharmaceutical arena remain optimistic that this year will see a reversal of that trend.
Legislation pending in both houses of Congress regarding DIR, or direct and indirect remuneration, fees are giving hope to drug stores and two of the industry’s largest advocacy groups that pharmacy benefits management companies will stop retroactively reducing payments.
There is no question that one of the top nonprescription categories contributing to both sales and foot traffic right now is allergy. Sales of nasal sprays — the category that captures all of the latest nasal corticosteroid Rx-to-OTC switches — are up 10.2%.
This could be the year. Movement again is occurring in Congress on legislation that would confer professional provider status on pharmacists serving millions of older Americans in many parts of the country.
Breakthrough brands, defined as those brands either introduced within the 52 weeks ended Dec. 25, 2016, or those brands that experienced blockbuster incremental growth in that time frame, feature leading meal-replacement solutions.
Sales of all OTC medicines and natural supplements broke records in 2016, reaching $45.8 billion for the 52 weeks ended Dec. 25, 2016, according to IRI. That’s an additional $1.8 billion in sales volume compared with a year ago.
Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.
Sales of durable medical equipment and the kind of home health products that help transition patient care from hospital settings to the home in the retail setting have only one direction to go. And that’s up.
DSN senior editor Michael Johnsen examines the hottest trends in OTC — including breakthrough brands and such growth categories as therables, sleep, allergy, cough-cold and more — in this multi-page report.